GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Ringpu Bio-Technology Co Ltd (SZSE:300119) » Definitions » EV-to-Revenue

Tianjin Ringpu Bio-Technology Co (SZSE:300119) EV-to-Revenue : 2.86 (As of May. 02, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Tianjin Ringpu Bio-Technology Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Tianjin Ringpu Bio-Technology Co's enterprise value is ¥6,696 Mil. Tianjin Ringpu Bio-Technology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,339 Mil. Therefore, Tianjin Ringpu Bio-Technology Co's EV-to-Revenue for today is 2.86.

The historical rank and industry rank for Tianjin Ringpu Bio-Technology Co's EV-to-Revenue or its related term are showing as below:

SZSE:300119' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.44   Med: 4.96   Max: 12.94
Current: 2.73

During the past 13 years, the highest EV-to-Revenue of Tianjin Ringpu Bio-Technology Co was 12.94. The lowest was 2.44. And the median was 4.96.

SZSE:300119's EV-to-Revenue is ranked worse than
55.43% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs SZSE:300119: 2.73

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-02), Tianjin Ringpu Bio-Technology Co's stock price is ¥16.39. Tianjin Ringpu Bio-Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥5.06. Therefore, Tianjin Ringpu Bio-Technology Co's PS Ratio for today is 3.24.


Tianjin Ringpu Bio-Technology Co EV-to-Revenue Historical Data

The historical data trend for Tianjin Ringpu Bio-Technology Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Ringpu Bio-Technology Co EV-to-Revenue Chart

Tianjin Ringpu Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.05 3.92 5.20 3.83 3.20

Tianjin Ringpu Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.42 3.60 3.64 3.20 2.61

Competitive Comparison of Tianjin Ringpu Bio-Technology Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Ringpu Bio-Technology Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Ringpu Bio-Technology Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Ringpu Bio-Technology Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Tianjin Ringpu Bio-Technology Co's EV-to-Revenue falls into.



Tianjin Ringpu Bio-Technology Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Tianjin Ringpu Bio-Technology Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6696.371/2339.381
=2.86

Tianjin Ringpu Bio-Technology Co's current Enterprise Value is ¥6,696 Mil.
Tianjin Ringpu Bio-Technology Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,339 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Ringpu Bio-Technology Co  (SZSE:300119) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Tianjin Ringpu Bio-Technology Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=16.39/5.055
=3.24

Tianjin Ringpu Bio-Technology Co's share price for today is ¥16.39.
Tianjin Ringpu Bio-Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Ringpu Bio-Technology Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Tianjin Ringpu Bio-Technology Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Ringpu Bio-Technology Co (SZSE:300119) Business Description

Traded in Other Exchanges
N/A
Address
No.6, Liujing Road, Developing Zone, Tianjin, CHN, 300300
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company. It is engaged in biotechnology and animal medicine, focusing on the national demand for agricultural sustainable development. The company provides products for Poultry; Swine; Pet; Aquatic; and Cattle and Sheep.

Tianjin Ringpu Bio-Technology Co (SZSE:300119) Headlines

No Headlines